83 related articles for article (PubMed ID: 23479148)
1. Association between CASP-8 gene polymorphisms and cancer risk in some Asian population based on a HuGE review and meta-analysis.
Zhang YJ; Zhong XP; Chen Y; Liu SR; Wu G; Liu YF
Genet Mol Res; 2013 Feb; 12(4):6466-76. PubMed ID: 23479148
[TBL] [Abstract][Full Text] [Related]
2. A literature-based systematic HuGE review and meta-analysis show that CASP gene family polymorphisms are associated with risk of lung cancer.
Zhang ZY; Xuan Y; Jin XY; Tian X; Wu R
Genet Mol Res; 2013 Jan; 12(3):3057-69. PubMed ID: 23315881
[TBL] [Abstract][Full Text] [Related]
3. CASP-9 gene functional polymorphisms and cancer risk: a large-scale association study plus meta-analysis.
Zhang ZY; Xuan Y; Jin XY; Tian X; Wu R
Genet Mol Res; 2013 Feb; 12(3):3070-8. PubMed ID: 23479167
[TBL] [Abstract][Full Text] [Related]
4. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
Ji GH; Li M; Cui Y; Wang JF
Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
[TBL] [Abstract][Full Text] [Related]
5. CASP-8 -652 6N ins/del polymorphism and cancer risk: A literature-based systematic HuGE review and meta-analysis.
Chen D; Ma T; Liu XW; Liu Z
Exp Ther Med; 2012 Oct; 4(4):762-770. PubMed ID: 23170140
[TBL] [Abstract][Full Text] [Related]
6. Association between IL-1RN gene polymorphisms and susceptibility to ankylosing spondylitis: a large Human Genome Epidemiology review and meta-analysis.
Jin GX; Duan JZ; Guo WL; Li L; Cui SQ; Wang H
Genet Mol Res; 2013 May; 12(2):1720-30. PubMed ID: 23765978
[TBL] [Abstract][Full Text] [Related]
7. HuGE systematic review and meta-analysis demonstrate association of CASP-3 and CASP-7 genetic polymorphisms with cancer risk.
Yan S; Li YZ; Zhu XW; Liu CL; Wang P; Liu YL
Genet Mol Res; 2013 May; 12(2):1561-73. PubMed ID: 23765963
[TBL] [Abstract][Full Text] [Related]
8. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
[TBL] [Abstract][Full Text] [Related]
9. Role of CASP-10 gene polymorphisms in cancer susceptibility: a HuGE review and meta-analysis.
Yan S; Li YZ; Zhu JW; Liu CL; Wang P; Liu YL
Genet Mol Res; 2012 Nov; 11(4):3998-4007. PubMed ID: 23212337
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms and haplotypes in caspases 8 and 9 genes and risk for prostate cancer: a case-control study in cohort of North India.
George GP; Mandal RK; Kesarwani P; Sankhwar SN; Mandhani A; Mittal RD
Urol Oncol; 2012; 30(6):781-9. PubMed ID: 21396853
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of an association of codon 72 polymorphisms of the p53 gene with increased endometrial cancer risk.
Gu Y; Zhou X; Zhang SL
Genet Mol Res; 2011 Oct; 10(4):3609-19. PubMed ID: 22057999
[TBL] [Abstract][Full Text] [Related]
13. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
Zhang F; Yang Y; Guo C; Wang Y
Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
[TBL] [Abstract][Full Text] [Related]
14. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2 gene polymorphisms and cancer susceptibility: a meta-analysis.
Wang X; Li J; Xie W; Zhang W; Chang Y
Neoplasma; 2013; 60(4):459-67. PubMed ID: 23581420
[TBL] [Abstract][Full Text] [Related]
16. Association between Ser311Cys polymorphism in the dopamine D2 receptor gene and schizophrenia risk: a meta-analysis in Asian populations.
Liu ZW; Liu JL; An Y; Zhang L; Wang YM
Genet Mol Res; 2012 Feb; 11(1):261-70. PubMed ID: 22370928
[TBL] [Abstract][Full Text] [Related]
17. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
18. Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis.
Hu Z; Li X; Yuan R; Ring BZ; Su L
Breast Cancer Res Treat; 2010 Apr; 120(3):705-14. PubMed ID: 19657731
[TBL] [Abstract][Full Text] [Related]
19. The association between UGT1A7 polymorphism and cancer risk: a meta-analysis.
Han SX; Wang L; Wu DQ
Cancer Epidemiol; 2012 Aug; 36(4):e201-6. PubMed ID: 22402308
[TBL] [Abstract][Full Text] [Related]
20. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk.
Liu B; Zhang Y; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K
Mol Carcinog; 2010 Jan; 49(1):75-84. PubMed ID: 19795398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
